Denali Oncology Group
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2010 | 36,361 | 28,274 | 8,087 | 22.5 | — |
| 2015 | 141,500 | 61,364 | 80,136 | 33.5 | — |
| 2016 | 83,050 | 25,745 | 57,305 | 106.5 | — |
| 2017 | 67,500 | 17,622 | 49,878 | 189.5 | — |
| 2018 | 92,500 | 27,132 | 65,368 | 152.0 | — |
| 2019 | 107,500 | 81,553 | 25,947 | 54.4 | — |
| 2020 | 44,375 | 14,495 | 29,880 | 330.7 | — |
| 2021 | 24,912 | 43,051 | −18,139 | 106.3 | — |
| 2023 | 105,000 | 51,309 | 53,691 | 102.6 | — |
In its most recent public year (2023), this organization brought in $53,691 more than it spent. Its reserves stood at about 102.6 months of spending, up from 22.5 in 2010.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
A new entry when its next filing is released. No account, no email; works in any feed reader, Slack, or automation tool. How following works